Issn Print: 0385-2407
Publication Date: 2017/08/01
Apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of Japanese patients with moderate to severe plaque psoriasis: Efficacy, safety and tolerability results from a phase 2b randomized controlled trial
Mamitaro Ohtsuki; Yukari Okubo; Mayumi Komine; Shinichi Imafuku; Robert M. Day; Peng Chen; Rosemary Petric; Allan Maroli; Osamu Nemoto
Author Information: Jichi Medical University
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.